Development of Molecular Imaging System for Aeessment of Heart Failure

Development of Molecular Imaging System for Aeessment of Heart Failure - Molecular Imaging System for Aeessment of Heart Failure

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004620

Enrollment

Registered

2010-11-25

Start date

2010-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

C-11 Acetate PET C-11 Hydroxyephedrine PET Echocardiography

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Coronary heart disease 2. Heart failure patients

Exclusion criteria

Exclusion criteria: 1. Unstable angina or myocardial infarction at acute stage 2. Decompensated heart failure 3. Pregnant women

Design outcomes

Primary

Measure	Time frame
C-11 Acetate PET C-11 Hydroxyephedrine PET Echocardiographic measurements	—

Secondary

Measure	Time frame
Other imaging biomarkers such as Tc-99m MIBI or I-123 MIBG Cardiovascular events	—

Countries

Japan

Contacts

Public ContactTakayoshi Hoshiba

The Medical and Pharmacological Research Center Foundation Administration

soumu1@mprcf.or.jp0767-26-3311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026